Recent Finacing
Recent Raise
Impact Therapeutics is a Nanjing-based clinical-stage biopharmaceutical company developing DNA damage response-targeted oncology therapeutics, advancing PARP inhibitor IMP4297 and multiple Wee1, ATR and Hedgehog pathway programs through clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
